Transient receptor potential ankyrin 1 (TRPA1)-mediated toxicity: friend or foe?

Toxicol Mech Methods. 2020 Jan;30(1):1-18. doi: 10.1080/15376516.2019.1652872. Epub 2019 Oct 28.

Abstract

Transient receptor potential (TRP) channels have been widely studied during the last decade. New studies uncover new features and potential applications for these channels. TRPA1 has a huge distribution all over the human body and has been reported to be involved in different physiological and pathological conditions including cold, pain, and damage sensation. Considering its role, many studies have been devoted to evaluating the role of this channel in the initiation and progression of different toxicities. Accordingly, we reviewed the most recent studies and divided the role of TRPA1 in toxicology into the following sections: neurotoxicity, cardiotoxicity, dermatotoxicity, and pulmonary toxicity. Acetaminophen, heavy metals, tear gases, various chemotherapeutic agents, acrolein, wood smoke particulate materials, particulate air pollution materials, diesel exhaust particles, cigarette smoke extracts, air born irritants, sulfur mustard, and plasticizers are selected compounds and materials with toxic effects that are, at least in part, mediated by TRPA1. Considering the high safety of TRPA1 antagonists and their efficacy to resolve selected toxic or adverse drug reactions, the future of these drugs looks promising.

Keywords: TRPA1; cold; neurotoxicity; pain; respiratory system; toxicology.

Publication types

  • Review

MeSH terms

  • Animals
  • Antidotes / therapeutic use
  • Cardiotoxicity
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / physiopathology
  • Humans
  • Lung Diseases / chemically induced*
  • Lung Diseases / drug therapy
  • Lung Diseases / metabolism
  • Lung Diseases / physiopathology
  • Membrane Transport Modulators / adverse effects*
  • Neurotoxicity Syndromes / drug therapy
  • Neurotoxicity Syndromes / etiology*
  • Neurotoxicity Syndromes / metabolism
  • Neurotoxicity Syndromes / physiopathology
  • Risk Assessment
  • Risk Factors
  • Signal Transduction
  • Skin Diseases / chemically induced*
  • Skin Diseases / drug therapy
  • Skin Diseases / metabolism
  • Skin Diseases / physiopathology
  • TRPA1 Cation Channel / agonists*
  • TRPA1 Cation Channel / antagonists & inhibitors
  • TRPA1 Cation Channel / metabolism

Substances

  • Antidotes
  • Membrane Transport Modulators
  • TRPA1 Cation Channel